Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS for Kidney Cancer Subtyping and Staging
NCT04021238Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Oct 2020
- Primary completion
- Aug 2022
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perflutren lipid microspheres, sulfur hexafluoride in kidney cancer, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Oct 2020; status: completed.
02
Drugs
perflutren lipid microspheressulfur hexafluoride
03
Conditions
kidney cancer
Beyond the preview
Go deeper on NCT04021238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04021238.